N/A
Completed N=8
Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
Androgenic Alopecia
Source: ClinicalTrials.gov NCT04341363 ↗
Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcomePrimary: Total Area Hair Count — 126.8 hairs per cm^2
Summary
The intent of this study is to evaluate the efficacy of microneedling through use of a professional tattoo machine in hair regrowth in patients with androgenic alopecia (AGA) over up to 6 treatments (6 months).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Total Area Hair Count |
126.8 | — |
| SECONDARY SALT Score |
15.5 | — |
| SECONDARY Hair Shaft Diameter |
54.4 | — |
| SECONDARY Number of Follicular Units |
108.8 | — |
| SECONDARY Vellus Hairs |
18.0 | — |
| SECONDARY Terminal Hairs |
104.3 | — |
Eligibility Criteria
Inclusion Criteria
- Symmetric hair loss from AGA
- Hamilton-Norwood IIIa, III, III vertex, IV, Iva, V with low density hair coverage over majority of alopecic areas
- No or minimal scalp hair regrowth on oral and/or topical minoxidil
Exclusion Criteria
- Any male with hair loss for other reasons
- Unilateral or asymmetric hair loss
- Hamilton-Norwood I, II, IIa, Va, IV, VII x
- Patients without hair
- Patients with the following who would make poor candidates for microneedling such as skin conditions, diabetes, or history of keloid formation
- Anything additional existing comorbidities that in the opinion of the investigator may cause unnecessary risk for the patient to participate
Data sourced from ClinicalTrials.gov (NCT04341363). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.